| [1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68:394-424.
|
| [2] |
Rapado-González ó, álvarez-Castro A, López-López R, et al. Circulating microRNAs as promising biomarkers in colorectal cancer[J]. Cancers, 2019, 11:898.doi:10.3390/cancers11070898.
|
| [3] |
Wang S, Zhang K, Tan S, et al. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies[J]. Mol Cancer, 2021, 20:13.doi:10.1186/s12943-020-01298-z.
|
| [4] |
Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic implementation issues and future challenges[J]. Nat Rev Clin Oncol, 2021, 18:297-312.
|
| [5] |
Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy[J]. Signal Transduct Target Ther, 2020, 5:145.doi:10.1038/s41392-020-00261-0.
|
| [6] |
Rinn JL, Chang HY. Long Noncoding RNAs: molecular modalities to organismal functions[J]. Annu Rev Biochem, 2020, 89:283-308.
|
| [7] |
Mehryab F, Rabbani S, Shahhosseini S, et al. Exosomes as a next-generation drug delivery system: an update on drug loading approaches, characterization, and clinical application challenges[J]. Acta Biomater, 2020, 113:42-62.
|
| [8] |
Yue B, Yang H, Wang J, et al. Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis[J]. Cell Prolif, 2020, 53:e12857.doi:10.1111/cpr.12857.
|
| [9] |
Goodall GJ, Wickramasinghe VO. RNA in cancer[J]. Nat Rev Cancer, 2021, 21:22-36.
|
| [10] |
Yao R, Wang Y, Chen L. Cellular functions of long noncoding RNAs[J]. Nature Cell Biology, 2019, 21:542-551.
|
| [11] |
Liu ZW, Zhao N, Su YN, et al. Exogenously overex-pressed intronic long noncoding RNAs activate host gene expression by affecting histone modification in arabidopsis[J]. Sci Rep, 2020, 10:3094.doi:10.1038/s41598-020-59697-7.
|
| [12] |
Lu C, Wei Y, Wang X, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma[J]. Mol Cancer, 2020, 19:28.doi:10.1186/s12943-020-1137-5.
|
| [13] |
Han M, Wang S, Fritah S, et al. Interfering with long non-coding RNA MIR22HG processing inhibits glioblas-toma progression through suppression of Wnt/β-catenin signalling[J]. Brain, 2020, 143:512-530.
|
| [14] |
Liang ZX, Liu HS, Wang FW, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J]. Cell Death Dis, 2019, 10:829.doi:10.1138/s41419-019-2077-0.
|
| [15] |
Cai H, Yu Y, Ni X, et al. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis[J]. Cell Death Dis, 2020, 11:1032.doi:10.1038/s41419-020-03247-6.
|
| [16] |
Luan Y, Li X, Luan Y, et al. Circulating lncRNA UCA1 promotes malignancy of colorectal cancer via the miR-143/MYO6 axis[J]. Mol Ther Nucleic Acids, 2020, 19:790-803.
|
| [17] |
Barbagallo C, Brex D, Caponnetto A, et al. LncRNA UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA interactions[J]. Mol Ther Nucleic Acids, 2018, 12:229-241.
|
| [18] |
Yang YN, Zhang R, Du JW, et al. Predictive role of UCA1-containing exosomes in cetuximab-resistant color-ectal cancer[J]. Cancer Cell Int, 2018, 18:164.doi:10.1186/s12935-018-0660-6.
|
| [19] |
Yu B, Du Q, Li H, et al. Diagnostic potential of serum exosomal colorectal neoplasia differentially expressed long non-coding RNA (CRNDE-p) and microRNA-217 expression in colorectal carcinoma[J]. Oncotarget, 2017, 8:83745-83753.
|
| [20] |
Sun J, Jia H, Bao X, et al. Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer[J]. Cell Death Dis, 2021, 12:123.doi:10.1038/s41419-020-03376-y.
|
| [21] |
Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19[J]. Theranostics, 2018, 8:3932-3948.
|
| [22] |
Oehme F, Krahl S, Gyorffy B, et al. Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer[J]. RNA Biol, 2019, 16:1339-1345.
|
| [23] |
Zhao Y, Du T, Du L, et al. Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer[J]. Cell Death Dis, 2019, 10:568.doi:10.1038/s41419-019-1804-x.
|
| [24] |
Wang L, Duan W, Yan S, et al. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer[J]. Biomed Pharmacother, 2019, 113:108758.doi:1016/j.biopha.2019.108758.
|
| [25] |
Choi JU, Park IK, Lee YK, et al. The biological function and therapeutic potential of exosomes in cancer: exosomes as efficient nanocommunicators for cancer therapy[J]. Int J Mol Sci, 2020, 21:7363.doi:10.3390/ijms21197363.
|
